Current
Neuro-Oncology

Volume 19 Number 7
31 July 2017

Home > Publications > Current Neuro-Oncology > Volume 19, Year 2017 > Number 7, 31 July

Jovanovic M, Radenkovic S, Stosic-Opincal T, Lavrnic S, Gavrilovic S, Lazovic-Popovic B, Soldatovic I, Maksimovic R.
Differentiation between progression and pseudoprogresion by arterial spin labeling MRI in patients with glioblastoma multiforme.
J BUON. 2017 Jul-Aug;22(4):1061-1067→. PMID: 28952228→. Interventional study. ˍ

Ravikanth R.
Advanced Magnetic Resonance Imaging of Glioblastoma Multiforme.
J Neurosci Rural Pract. 2017 Jul-Sep;8(3):439-440→. doi: 10.4103/jnrp.jnrp_423_16→. PMID: 28694628→. Case report. ˍ

Sekerdag E, Lüle S, Bozdağ Pehlivan S, Öztürk N, Kara A, Kaffashi A, Vural I, Işıkay I, Yavuz B, Oguz KK, Söylemezoğlu F, Gürsoy-Özdemir Y, Mut M.
A potential non-invasive glioblastoma treatment: Nose-to-brain delivery of farnesylthiosalicylic acid incorporated hybrid nanoparticles.
J Control Release. 2017 Jul 3, 2017;261:187-198→. doi: 10.1016/j.jconrel.2017.06.032→. PMID: 28684169→. Laboratory investigation. ˍ

Malmström A, Poulsen HS, Grønberg BH, Stragliotto G, Hansen S, Asklund T, Holmlund B, Łysiak M, Dowsett J, Kristensen BW, Söderkvist P, Rosell J, Henriksson R; Nordic Clinical Brain Tumor Study Group (NCBTSG).
Postoperative neoadjuvant temozolomide before radiotherapy versus standard radiotherapy in patients 60 years or younger with anaplastic astrocytoma or glioblastoma: a randomized trial.
Acta Oncol. 2017 Jul 4, 2017;56(12):1776-1785→. doi: 10.1080/0284186X.2017.1332780→. PMID: 28675067→. Interventional study. ˍ

Field KM, Phal PM, Fitt G, Goh C, Nowak AK, Rosenthal MA, Simes J, Barnes EH, Sawkins K, Cher LM, Hovey EJ, Wheeler H.
The role of early magnetic resonance imaging in predicting survival on bevacizumab for recurrent glioblastoma: Results from a prospective clinical trial (CABARET).
Cancer. 2017 Jul 5, 2017;123(18):3576-3582→. doi: 10.1002/cncr.30838→. PMID: 28678383→. Interventional study. ˍ

Miller TE, Liau BB, Wallace LC, Morton AR, Xie Q, Dixit D, Factor DC, Kim LJY, Morrow JJ, Wu Q, Mack SC, Hubert CG, Gillespie SM, Flavahan WA, Hoffmann T, Thummalapalli R, Hemann MT, Paddison PJ, Horbinski CM, Zuber J, Scacheri PC, Bernstein BE, Tesar PJ, Rich JN.
Transcription elongation factors represent in vivo cancer dependencies in glioblastoma.
Nature. 2017 Jul 5, 2017;547(7663):355-359→. doi: 10.1038/nature23000→. PMID: 28678782→. Laboratory investigation. ˍ

Northcott PA.
Cancer: Keeping it real to kill glioblastoma.
Nature. 2017 Jul 5, 2017;547(7663):291-292→. doi: 10.1038/nature23095→. PMID: 28678780→. Comment. ˍ
Refers to: Miller TE, et al., Transcription elongation factors represent in vivo cancer dependencies in glioblastoma.
Nature. 2017 Jul 5, 2017;547(7663):355-359→. doi: 10.1038/nature23000→. PMID: 28678782→. Laboratory investigation. ˍ

Haque W, Verma V, Butler EB, Teh BS.
Definitive chemoradiation at high volume facilities is associated with improved survival in glioblastoma.
J Neurooncol. 2017 Jul 7, 2017;135(1):173-181→. doi: 10.1007/s11060-017-2563-0→. PMID: 28687924→. Observational study. ˍ

Thippu Jayaprakash K, Wildschut K, Jena R.
Feasibility of Hippocampal Avoidance Radiotherapy for Glioblastoma.
Clin Oncol (R Coll Radiol). 2017 Jul 7, 2017;29(11):748-752→. doi: 10.1016/j.clon.2017.06.010→. PMID: 28693823→. Observational study. ˍ

Fariselli L, Cuppini L, Gaviani P, Marchetti M, Pinzi V, Milanesi I, Simonetti G, Tramacere I, DiMeco F, Salmaggi A, Silvani A.
Short course radiotherapy concomitant with temozolomide in GBM patients: a phase II study.
Tumori. 2017 Jul 7, 2017;103(5):457-463→. doi: 10.5301/tj.5000672→. PMID: 28708230→. Interventional study. ˍ

*

Wang Q, Hu B, Hu X, Kim H, Squatrito M, Scarpace L, deCarvalho AC, Lyu S, Li P, Li Y, Barthel F, Cho HJ, Lin YH, Satani N, Martinez-Ledesma E, Zheng S, Chang E, Sauvé CG, Olar A, Lan ZD, Finocchiaro G, Phillips JJ, Berger MS, Gabrusiewicz KR, Wang G, Eskilsson E, Hu J, Mikkelsen T, DePinho RA, Muller F, Heimberger AB, Sulman EP, Nam DH, Verhaak RGW.
Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment.
Cancer Cell. 2017 Jul 10, 2017;32(1):42-56.e6→. doi: 10.1016/j.ccell.2017.06.003→. PMID: 28697342→. Laboratory investigation. ˍ

Quick-Weller J, Tritt S, Behmanesh B, Mittelbronn M, Spyrantis A, Dinc N, Weise L, Seifert V, Marquardt G, Freiman TM.
Biopsies of pediatric brainstem lesions display low morbidity but strong impact on further treatment decisions.
J Clin Neurosci. 2017 Jul 12, 2017;44:254-259→. doi: 10.1016/j.jocn.2017.06.028→. PMID: 28711290→. Case report. ˍ

Du W, Seah I, Bougazzoul O, Choi G, Meeth K, Bosenberg MW, Wakimoto H, Fisher D, Shah K.
Stem cell-released oncolytic herpes simplex virus has therapeutic efficacy in brain metastatic melanomas.
Proc Natl Acad Sci U S A. 2017 Jul 14, 2017;114(30):E6157-E6165→. doi: 10.1073/pnas.1700363114→. PMID: 28710334→. Laboratory investigation. ˍ

Gu J, Lu Z, Ji C, Chen Y, Liu Y, Lei Z, Wang L, Zhang HT, Li X.
Melatonin inhibits proliferation and invasion via repression of miRNA-155 in glioma cells.
Biomed Pharmacother. 2017 Jul 14, 2017;93:969-975→. doi: 10.1016/j.biopha.2017.07.010→. PMID: 28724215→. Laboratory investigation. ˍ

Behling F, Kaltenstadler M, Noell S, Schittenhelm J, Bender B, Eckert F, Tabatabai G, Tatagiba M, Skardelly M.
The prognostic impact of ventricular opening in glioblastoma surgery: a retrospective single center analysis.
World Neurosurg. 2017 Jul 18, 2017;106:615-624→. doi: 10.1016/j.wneu.2017.07.034→. PMID: 28729143→. Observational study. ˍ

Desai VCA, Quinlan SC, Deitz AC, He J, Holick CN, Lanes S.
Risk of severe acute liver injury among patients with brain cancer treated with temozolomide: a nested case-control study using the healthcore integrated research database.
J Neurooncol. 2017 Jul 17, 2017;134(1):89-95→. doi: 10.1007/s11060-017-2489-6→. PMID: 28717885→. Observational study. ˍ

Eun CS, Lim JS, Lee J, Lee SP, Yang SA.
The protective effect of fermented Curcuma longa L. on memory dysfunction in oxidative stress-induced C6 gliomal cells, proinflammatory-activated BV2 microglial cells, and scopolamine-induced amnesia model in mice.
BMC Complement Altern Med. 2017 Jul 17, 2017;17(1):367→. doi: 10.1186/s12906-017-1880-3→. PMID: 28716085→. Laboratory investigation. ˍ

Maschio M, Beghi E, Casazza MML, Colicchio G, Costa C, Banfi P, Quadri S, Aloisi P, Giallonardo AT, Buttinelli C, Pauletto G, Striano S, Salmaggi A, Terenzi R, Daniele O, Crichiutti G, Paladin F, Rossi R, Prato G, Vigevano F, De Simone R, Ricci F, Saladini M, Monti F, Casellato S, Zanoni T, Giannarelli D, Avanzini G, Aguglia U; BTRE Study Group.
Patterns of care of brain tumor-related epilepsy. A cohort study done in Italian Epilepsy Center.
PLoS One. 2017 Jul 17, 2017;12(7):e0180470→. doi: 10.1371/journal.pone.0180470→. PMID: 28715490→. Observational study. ˍ

Vietheer JM, Rieger J, Wagner M, Senft C, Tichy J, Foerch C.
Serum concentrations of glial fibrillary acidic protein (GFAP) do not indicate tumor recurrence in patients with glioblastoma.
J Neurooncol. 2017 Jul 17, 2017;135(1):193-199→. doi: 10.1007/s11060-017-2565-y→. PMID: 28717884 ˍ. Interventional study. ˍ

Galante JR, Rodriguez F, Grossman SA, Strowd RE.
Late post-treatment radiographic changes 3 years following chemoradiation for glioma: the importance of histopathology.
CNS Oncol. 2017 Jul 18, 2017;6(3):195-201→. doi: 10.2217/cns-2016-0040→. PMID: 28718307→. Case report. ˍ

Pessina F, Navarria P, Cozzi L, Tomatis S, Clerici E, Ascolese AM, Simonelli M, Perrino M, Riva M, Rossi M, Rudà R, Santoro A, Bello L, Scorsetti M.
Outcome evaluation of patients with newly diagnosed anaplastic gliomas treated in a single institution.
CNS Oncol. 2017 Jul 18, 2017;6(3):211-9→. doi: 10.2217/cns-2016-0043→. PMID: 28718305→. Observational study. ˍ

Prasad GL.
Primary Spinal Cord Glioblastoma Multiforme: A Rare but Uniformly Fatal Neoplasm.
World Neurosurg. 2017 Jul 18, 2017;104:1020-1021→. doi: 10.1016/j.wneu.2017.02.125→. PMID: 28732416→. Comment. ˍ
Refers to: Behmanesh B, et al., Management of Patients with Primary Intramedullary Spinal Cord Glioblastoma.
World Neurosurg. 2016 Oct 21, 2017;98:198-202→. doi: 10.1016/j.wneu.2016.10.075→. PMID: 27777151→. Observational study. ˍ

Zanello M, Roux A, Ursu R, Peeters S, Bauchet L, Noel G, Guyotat J, Le Reste PJ, Faillot T, Litre F, Desse N, Emery E, Petit A, Peltier J, Voirin J, Caire F, Barat JL, Vignes JR, Menei P, Langlois O, Dezamis E, Carpentier A, Dam Hieu P, Metellus P, Pallud J; On the Behalf of the Club de Neuro-Oncologie of the Société Française de Neurochirurgie.
Recurrent glioblastomas in the elderly after maximal first-line treatment: does preserved overall condition warrant a maximal second-line treatment?
J Neurooncol. 2017 Jul 19, 2017;135(2):285-297→. doi: 10.1007/s11060-017-2573-y→. PMID: 28726173→. Observational study. ˍ

Lehrer S, Green S, Rosenzweig KE.
Risk of malignant brain tumor as a second primary is significantly reduced after treatment of breast cancer.
Breast J. 2017 Jul 20, 2018;24(2):219-220→. doi: 10.1111/tbj.12880→. PMID: 28727226→. Letter to the Editor / Observational study. ˍ

⋆

Northcott PA, Buchhalter I, Morrissy AS, Hovestadt V, Weischenfeldt J, Ehrenberger T, Gröbner S, Segura-Wang M, Zichner T, Rudneva VA, Warnatz HJ, Sidiropoulos N, Phillips AH, Schumacher S, Kleinheinz K, Waszak SM, Erkek S, Jones DTW, Worst BC, Kool M, Zapatka M, Jäger N, Chavez L, Hutter B, Bieg M, Paramasivam N, Heinold M, Gu Z, Ishaque N, Jäger-Schmidt C, Imbusch CD, Jugold A, Hübschmann D, Risch T, Amstislavskiy V, Gonzalez FGR, Weber UD, Wolf S, Robinson GW, Zhou X, Wu G, Finkelstein D, Liu Y, Cavalli FMG, Luu B, Ramaswamy V, Wu X, Koster J, Ryzhova M, Cho YJ, Pomeroy SL, Herold-Mende C, Schuhmann M, Ebinger M, Liau LM, Mora J, McLendon RE, Jabado N, Kumabe T, Chuah E, Ma Y, Moore RA, Mungall AJ, Mungall KL, Thiessen N, Tse K, Wong T, Jones SJM, Witt O, Milde T, Von Deimling A, Capper D, Korshunov A, Yaspo ML, Kriwacki R, Gajjar A, Zhang J, Beroukhim R, Fraenkel E, Korbel JO, Brors B, Schlesner M, Eils R, Marra MA, Pfister SM, Taylor MD, Lichter P.
The whole-genome landscape of medulloblastoma subtypes.
Nature. 2017 Jul 20, 2017;547(7663):311-317→. doi: 10.1038/nature22973→. PMID: 28726821→. Laboratory investigation. ˍ

van Linde ME, Brahm CG, de Witt Hamer PC, Reijneveld JC, Bruynzeel AME, Vandertop WP, van de Ven PM, Wagemakers M, van der Weide HL, Enting RH, Walenkamp AME, Verheul HMW.
Treatment outcome of patients with recurrent glioblastoma multiforme: a retrospective multicenter analysis.
J Neurooncol. 2017 Jul 20, 2017;135(1):183-192→. doi: 10.1007/s11060-017-2564-z→. PMID: 28730289→. Observational study. ˍ

Abbassy M, Missios S, Barnett GH, Brewer C, Peereboom DM, Ahluwalia M, Neyman G, Chao ST, Suh JH, Vogelbaum MA.
Phase I Trial of Radiosurgery Dose Escalation Plus Bevacizumab in Patients With Recurrent/Progressive Glioblastoma.
Neurosurgery. 2017 Jul 21, 2018;83(3):385-392→. doi: 10.1093/neuros/nyx369→. PMID: 28973311→. Interventional study. ˍ

Marinoff AE, Ma C, Guo D, Snuderl M, Wright KD, Manley PE, Al-Sayegh H, Sinai CE, Ullrich NJ, Marcus K, Haas-Kogan D, Goumnerova L, London WB, Kieran MW, Chi SN, Fangusaro J, Bandopadhayay P.
Rethinking childhood ependymoma: a retrospective, multi-center analysis reveals poor long-term overall survival.
J Neurooncol. 2017 Jul 21, 2017;135(1):201-211→. doi: 10.1007/s11060-017-2568-8→. PMID: 28733870→. Observational study. ˍ

*

Park JE, Ryu KH, Kim HS, Kim HW, Shim WH, Jung SC, Choi CG, Kim SJ, Kim JH.
Perfusion of surgical cavity wall enhancement in early post-treatment MR imaging may stratify the time-to-progression in glioblastoma.
PLoS One. 2017 Jul 21, 2017;12(7):e0181933→. doi: 10.1371/journal.pone.0181933→. PMID: 28732091→. Observational study. ˍ

He J, Li X, Zhu W, Li C, Gong J.
Posterior fossa pilomyxoid astrocytoma with spontaneous hemorrhage in pediatric patients.
Childs Nerv Syst. 2017 Jul 24, 2018;34(1):149-153→. doi: 10.1007/s00381-017-3549-0→. PMID: 28741227→. Case report. ˍ

Nathan JK, Brezzell AL, Kim MM, Leung D, Wilkinson DA, Hervey-Jumper SL.
Early initiation of chemoradiation following index craniotomy is associated with decreased survival in high-grade glioma.
J Neurooncol. 2017 Jul 25, 2017;135(2):325-333→. doi: 10.1007/s11060-017-2577-7→. PMID: 28744829→. Observational study. ˍ

Altieri R, Hirono S, Duffau H, Ducati A, Fontanella M, LA Rocca G, Melcarne A, Panciani PP, Spena G, Garbossa D.
Natural history of de novo High Grade Glioma: first description of growth parabola.
J Neurosurg Sci. 2017 Jul 26, 2020;64(4):399-403→. doi: 10.23736/S0390-5616.17.04067-X→. PMID: 28748908→. Case report. ˍ

Uzuka T, Takahashi H, Nakasu Y, Okuda T, Mitsuya K, Hayashi N, Hirose T, Kurai H.
Surgical Site Infection after Malignant Brain Tumor Resection: A Multicenter Study for Induction of a Basic Care Bundle.
Neurol Med Chir (Tokyo). 2017 Jul 26, 2017;57(10):542-547→. doi: 10.2176/nmc.oa.2017-0034→. PMID: 28747588→. Observational study. ˍ

Veldhuijzen van Zanten SEM, El-Khouly FE, Jansen MHA, Bakker DP, Sanchez Aliaga E, Haasbeek CJA, Wolf NI, Zwaan CM, Vandertop WP, van Vuurden DG, Kaspers GJL.
A phase I/II study of gemcitabine during radiotherapy in children with newly diagnosed diffuse intrinsic pontine glioma.
J Neurooncol. 2017 Jul 26, 2017;135(2):307-315→. doi: 10.1007/s11060-017-2575-9→. PMID: 28748343→. Interventional study. ˍ
Erratum in: Veldhuijzen van Zanten SEM, et al., Correction to: A phase I/II study of gemcitabine during radiotherapy in children with newly diagnosed diffuse intrinsic pontine glioma.
J Neurooncol. 2017 Oct 23, 2018;136(1):219-220→. doi: 10.1007/s11060-017-2636-0→. PMID: 29063425→. Correction. ˍ

Benmaamar R.
Redefining the molecular substructure of medulloblastoma.
Lancet Oncol. 2017 Jul 27, 2017;18(9):e514→. doi: 10.1016/S1470-2045(17)30571-5→. PMID: 28757377→. Comment. ˍ
Refers to: Northcott PA, et al., The whole-genome landscape of medulloblastoma subtypes.
Nature. 2017 Jul 20, 2017;547(7663):311-317→. doi: 10.1038/nature22973→. PMID: 28726821→. Laboratory investigation. ˍ

Liljehult MM, Buus L, Liljehult J, Rasmussen BK.
Walking ability in patients with glioblastoma: prognostic value of the Berg Balance Scale and the 10 meter walk test.
J Neurooncol. 2017 Jul 27, 2017;135(2):335-342→. doi: 10.1007/s11060-017-2579-5→. PMID: 28752499→. Observational study. ˍ

Tsang DS, Murphy ES, Lucas JT Jr, Lagiou P, Acharya S, Merchant TE.
Pseudoprogression in pediatric low-grade glioma after irradiation.
J Neurooncol. 2017 Jul 27, 2017;135(2):371-379→. doi: 10.1007/s11060-017-2583-9→. PMID: 28752498→. Observational study. ˍ

Zhai L, Ladomersky E, Lauing KL, Wu M, Genet M, Gritsina G, Győrffy B, Brastianos PK, Binder D, Sosman JA, Giles FJ, James CD, Horbinski C, Stupp R, Wainwright DA.
Infiltrating T cells increase IDO1 expression in glioblastoma and contribute to decreased patient survival.
Clin Cancer Res. 2017 Jul 27, 2017;23(21):6650-6660→. doi: 10.1158/1078-0432.CCR-17-0120→. PMID: 28751450→. Laboratory investigation. ˍ

Ambady P, Wu YJ, Walker JM, Kersch C, Pagel MA, Woltjer RL, Fu R, Muldoon LL, Neuwelt EA.
Enhancing the cytotoxicity of chemoradiation with radiation-guided delivery of anti-MGMT morpholino oligonucleotides in non-methylated solid tumors.
Cancer Gene Ther. 2017 Jul 28, 2017;24(8):348-357→. doi: 10.1038/cgt.2017.27→. PMID: 28752860→. Laboratory investigation. ˍ

Weaver KJ, Crawford LM, Bennett JA, Rivera-Zengotita ML, Pincus DW.
Brainstem angiocentric glioma: report of 2 cases.
J Neurosurg Pediatr. 2017 Jul 28, 2017;20(4):347-351→. doi: 10.3171/2017.5.PEDS16402→. PMID: 28753090→. Case report. ˍ